Megestrol Acetate Suspension
Product Images NDC 24979-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 24979-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5862d67-figure-01 (B5862d67 Figure 01)

FDA Label Image

B5862d67-figure-02 (B5862d67 Figure 02)

FDA Label Image

B5862d67-figure-03 (B5862d67 Figure 03)

FDA Label Image

B5862d67-figure-04 (B5862d67 Figure 04)

FDA Label Image

05 (B5862d67 Figure 05)

05 (B5862d67 Figure 05)
This is a product description of Megestrol Acetate Oral Suspension, USP, which is used only by prescription. It has a concentration of 625mg/5mL (125mg/mL) and comes in a concentrated formula of 150mL. The manufacturer is Twi NDC with a product code of 24979-041-13. The rest of the description is not readable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.